nabarsi.eu
Press Area / News
http://www.nabarsi.eu/en/press-area/news/1
Press Area / News. 10th International Symposoium on Amino-Acyl tRNA Synthetases. Several scientific posters were presented at the 10th International Symposium on Amino-Acyl tRNA Synthetases, Barcelona, 8th - 22nd October 2015. For further information see the 'ACTIVITIES' section of this website. InhibOX presents NABARSI work at the CCG user-group meeting. InhibOX presented a poster on their NABARSI work at the Chemical Computing Group (CCG) user-group meeting in London on May 12 - 15, London UK. The topi...
nabarsi.eu
Nabarsi / Team
http://www.nabarsi.eu/en/nabarsi
The NABARSI team consists of 5 partners:. Omnia Molecular S.L. Omnia Molecular uses its proprietary platform and design expertise to synthesize and develop novel anti-infectives targeted at difficult-to-treat infections. InhibOx is dedicated to developing and delivering the best services and technologies in computer-aided drug discovery (CADD). Latvian Institute of Organic Synthesis. The University of Leeds is one of the world's top 100 universities and part of the Russell Group of leading UK universities.
nabarsi.eu
Nabarsi / Objectives
http://www.nabarsi.eu/en/nabarsi/objectives/2
The main objective of the NABARSI project is to develop a Proof-of-Concept (PoC) for the discovery of new chemical entities (NCEs) as antibacterial drugs, and to exploit the results in conjunction with industry. Novel computational and screening technologies, synthetic methodology and advanced mechanistic studies will be combined with state-of-the-art drug discovery approaches in order to provide selective NCEs with high antibacterial efficacy and low resistance potential. Validation of this protein fami...
nabarsi.eu
Press Area / News
http://www.nabarsi.eu/en/press-area
Press Area / News. 10th International Symposoium on Amino-Acyl tRNA Synthetases. Several scientific posters were presented at the 10th International Symposium on Amino-Acyl tRNA Synthetases, Barcelona, 8th - 22nd October 2015. For further information see the 'ACTIVITIES' section of this website. InhibOX presents NABARSI work at the CCG user-group meeting. InhibOX presented a poster on their NABARSI work at the Chemical Computing Group (CCG) user-group meeting in London on May 12 - 15, London UK. The topi...
nabarsi.eu
Nabarsi / Work packages
http://www.nabarsi.eu/en/nabarsi/participants/5
Nabarsi / Work packages. In order to maximize time resources, the majority of the WPs will initiate as soon as the project commences (except for WP7 regarding Advanced Compound Characterization). Relevant WP activities will be carried out using reference or standard compounds (some aaRS inhibitor compounds are already available as controls) until NCE compounds have been generated, which will allow assay validation to begin as soon as possible and also will provide starting points for the project. Predict...
nabarsi.eu
Activities / Publications and patents
http://www.nabarsi.eu/en/activities/workshops/2
Activities / Publications and patents. Funded by a grant from the European Union Framework 7 (FP7) programme - Health.2013.2.31-1 - Grant agreement no: 601725. Xxxxx, S.L., through its website, will use the data supplied by the user for internal use in order to publicise offers and promotions that may be of interest to the user. Th user agrees to cede his/her personal details to other companies (hotels) belonging to xxxxx, S.L and to other companies with which collaboration agreements have been reach...
nabarsi.eu
Activities
http://www.nabarsi.eu/en/activities
Prof Lluis Ribas (Omnia) was one of the main organizers for the '10th International Conference on Aminoacyl-tRNA Synthetases (AARS)', which took place on the 18th to 22nd October 2015 in Barcelona, Spain. Funded by a grant from the European Union Framework 7 (FP7) programme - Health.2013.2.31-1 - Grant agreement no: 601725. Xxxxx, S.L., through its website, will use the data supplied by the user for internal use in order to publicise offers and promotions that may be of interest to the user. Th user agre...
nabarsi.eu
Nabarsi / Team
http://www.nabarsi.eu/en/nabarsi/team/3
The NABARSI team consists of 5 partners:. Omnia Molecular S.L. Omnia Molecular uses its proprietary platform and design expertise to synthesize and develop novel anti-infectives targeted at difficult-to-treat infections. InhibOx is dedicated to developing and delivering the best services and technologies in computer-aided drug discovery (CADD). Latvian Institute of Organic Synthesis. The University of Leeds is one of the world's top 100 universities and part of the Russell Group of leading UK universities.
nabarsi.eu
Activities
http://www.nabarsi.eu/en/activities/activities/1
Prof Lluis Ribas (Omnia) was one of the main organizers for the '10th International Conference on Aminoacyl-tRNA Synthetases (AARS)', which took place on the 18th to 22nd October 2015 in Barcelona, Spain. Funded by a grant from the European Union Framework 7 (FP7) programme - Health.2013.2.31-1 - Grant agreement no: 601725. Xxxxx, S.L., through its website, will use the data supplied by the user for internal use in order to publicise offers and promotions that may be of interest to the user. Th user agre...
SOCIAL ENGAGEMENT